SurModics, Inc (SRDX) revealed Loss for third quarter of -$5.318 million
The company's bottom line totaled -$5.318 million, or -$0.37 per share. This compares with -$7.554 million, or -$0.53 per share, last year.
The company's revenue for the period fell 2.6% to $29.567 million from $30.341 million last year.
SurModics, Inc earnings at a glance (GAAP) :
-Earnings: -$5.318 Mln. vs. -$7.554 Mln. last year.-EPS: -$0.37 vs. -$0.53 last year.-Revenue: $29.567 Mln vs. $30.341 Mln last year.
For the third quarter, the company posted adjusted income of $0.837 million, or $0.06 per share, compared with a loss of $3.880 million, or $0.27 per share, a year ago.
Looking ahead, for the full year, the company has revised its outlook.
SurModics now expects full-year net loss of $1.70 to $1.55 per share against the earlier outlook for loss of $1.60 to $1.40 per share.
The company now projects annual adjusted loss per share of $0.35 to $0.20 per share, compared with the earlier guidance for a loss of $0.62 to $0.42 per share.
This net and adjusted loss per share guidance assumes around $16 million of merger-related charges in fiscal 2025, compared to $3.7 million in fiscal 2024.
Surmodics has revised up its annual revenue outlook to a range of $116.5 million to $118.5 million, down 8% to 6% from fiscal 2024. Earlier, the company had expected its revenue to be in the range of $114 million to $117 million.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.